1. Thrombus straddling a patent foramen ovale in a patient with pulmonary embolism related to essential thrombocythemia

   • Jiang-Shan Tan
   • Xin-Xin Yan
   • Lu Hua

   Images in Hematology 02 January 2021 Pages: 159 - 160

   

2. Cytokeratin expression in therapy-related leukemia

   • Hiromi Kinoshita
   • Daisuke Okamura
   • Yasuhiro Ebihara

   Images in Hematology 01 January 2021 Pages: 161 - 162

   

3. Characterization of hereditary red blood cell membranopathies using combined targeted next-generation sequencing and osmotic gradient ektacytometry

   • Joan-Lluis Vives-Corrons
   • Elena Krishnevskaya
   • Agueda Ancochea

   Original Article 19 October 2020 Pages: 163 - 174

   

4. The impact of autoimmune cytopenias on the clinical course and survival of Hodgkin lymphoma

   • László Imre Pinczés
   • Roxána Szabó
   • Árpád Illés

   Original Article 15 October 2020 Pages: 175 - 182

   

5. Intensity of immune/clotting assays relate to multiple antiphospholipid antibody positivity in thrombotic primary antiphospholipid syndrome

   • Paul R. J. Ames
   • Mira Merashli
   • Antonio Ciampa

   Original Article 08 October 2020 Pages: 183 - 189

   

6. Direct oral anticoagulants in patients with severe inherited thrombophilia: a single-center cohort study

   • Joanna Zuk
   • Elzbieta Papuga-Szela
   • Anetta Undas

   Original Article 11 October 2020 Pages: 190 - 198

   

7. Platelet indices as a predictive marker in neonatal sepsis and respiratory distress in preterm prelabor rupture of membranes

   • Sanjay Mishra
   • Shyampyari Jaiswar
   • Neetu Mishra

   Original Article 27 October 2020 Pages: 199 - 206

   

8. Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents

   • Shuku Sato
   • Wataru Kamata
   • Yotaro Tamai

   Original Article 19 September 2020 Pages: 207 - 213

   

9. Chronic myeloid leukemia in solid organ transplant patients: a case series

   • Irina Amitai
   • Adi Shacham Abulafia
   • Jeffrey H. Lipton

   Original Article 06 October 2020 Pages: 214 - 218

10. Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR

    • Naoki Takezako
    • Hirohiko Shibayama
    • Shinsuke Iida

    Original Article 10 October 2020 Pages: 219 - 230

    

11. Transcriptional heterogeneity of clonal plasma cells and immune evasion in immunoglobulin light chain amyloidosis

    • Yujia Wang
    • Lushuang Xu
    • Jin Lu

    Original Article 10 October 2020 Pages: 231 - 242

    

12. Inhibition of CDK4/6 and autophagy synergistically induces apoptosis in t(8;21) acute myeloid leukemia cells

    • Kana Nakatani
    • Hidemasa Matsuo
    • Souichi Adachi

    Original Article 17 October 2020 Pages: 243 - 253

    

13. Salt-inducible kinase inhibition sensitizes human acute myeloid leukemia cells to all-trans retinoic acid-induced differentiation

    • Xue-Wen Zhang
    • Xing Shen
    • Yu-Wen Cong

    Original Article 19 October 2020 Pages: 254 - 262

    

14. Clinical features of 47 secondary hemophagocytic lymphohistiocytosis patients complicated with capillary leak syndrome

    • Changfeng Man
    • Mengmeng Wang
    • Hongxia Qiu

    Original Article 09 October 2020 Pages: 263 - 270

    

15. Medical database analysis of japanese multiple myeloma patients with planned stem cell transplantation (MEDALIST) – a focus on healthcare resource utilization and cost

    • Shinsuke Iida
    • Tadao Ishida
    • Takanori Teshima

    Original Article 15 October 2020 Pages: 271 - 278

    

16. The clonal evolution during long-term clinical course of multiple myeloma

    • Yuko Mishima
    • Yuji Mishima
    • Yasuhito Terui

    Case Report 30 August 2020 Pages: 279 - 284

    

17. Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion

    • Shuki Oya
    • Satoshi Morishige
    • Koji Nagafuji

    Case Report 19 September 2020 Pages: 285 - 289

    

18. Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation

    • Naoki Sakata
    • Munehiro Okano
    • Keisuke Sugimoto

    Case Report 31 August 2020 Pages: 290 - 296

    

19. Ruxolitinib for hematopoietic cell transplantation-associated hemophagocytic lymphohistiocytosis

    • Rintaro Ono
    • Miho Ashiarai
    • Daisuke Hasegawa

    Case Report 26 September 2020 Pages: 297 - 301

    

20. Bone marrow transplantation from a human leukocyte antigen-mismatched unrelated donor in a case with C1q deficiency associated with refractory systemic lupus erythematosus

    • Risa Matsumura
    • Shinji Mochizuki
    • Masao Kobayashi

    Case Report 30 September 2020 Pages: 302 - 307

    

21. Correction to: FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children’s Cancer Group

    • Tadashi Kumamoto
    • Hiroaki Goto
    • Hidemi Toyoda

    Correction 23 January 2021 Pages: 308 - 309